# VIDA Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vida-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: Coralville, US
- Website: www.vidalung.ai
- Total disclosed funding: $19M
- Latest round: Series C (Apr 15, 2020)
- Investors on record: 12

## About

Based in Iowa, US and founded in 2004, VIDA Diagnostics, Inc. operates as a developer of LungPrint®, an Artificial Intelligence-powered quantitative pulmonary analysis software for the treatment of chronic obstructive pulmonary disease (COPD), emphysema, lung cancer, asthma, and COVID-19. The company was co-founded by Eric A. Hoffman and Joseph M. Reinhardt and is backed by investors including First Analysis, Blue Heron Capital, Next Level Ventures, Unitypoint Health Ventures, and OSF Healthcare.

Vida provides two solutions namely VIDA Insights and VIDA Discovery. VIDA Insights combines data and machine learning to provide quantified lung measures and novel visualizations. It has the ability to detect the disease early, conducts the precise diagnosis, and gives systematic tracking and personalized treatments. VIDA Discovery modernizes the clinical trial process by providing quality, quantitative CT imaging analysis for all major lung and respiratory diseases.

The company recently received 510(k) clearance from the Food and Drug Administration (FDA) for enhancements to its LungPrint solution, including automated deep learning-based lung and lobe segmentation algorithms. The clearance further proves the quality and clinical efficacy of Vida’s artificial intelligence (AI)-powered precision imaging and analytics solutions.

## Funding rounds

- Series C, Apr 15, 2020, $2M — OSF Ventures
- Series C, Mar 12, 2020, $12M — First Analysis, The Angels' Forum, Rittenhouse Ventures, Blue Heron Capital, Corridor Management, Next Level Ventures, Chartline Capital Partners, RVF LP, UnityPoint Health Ventures
- Series B, Dec 20, 2016, $5.1M — Rittenhouse Ventures, Next Level Ventures, Chartline Capital Partners, RVF LP, AccelerateIT, Northern California Investment Fund

## Investors

- Rittenhouse Ventures (https://capitalatlas.ai/funds/rittenhouse-ventures) — Series B, Series C
- Next Level Ventures (https://capitalatlas.ai/funds/next-level-ventures) — Series B, Series C
- Chartline Capital Partners (https://capitalatlas.ai/funds/chartline-capital-partners) — Series B, Series C
- RVF LP — Series B, Series C
- AccelerateIT (https://capitalatlas.ai/funds/accelerateit) — Series B
- Northern California Investment Fund — Series B
- First Analysis (https://capitalatlas.ai/funds/first-analysis) — Series C
- The Angels' Forum (https://capitalatlas.ai/funds/the-angels-forum) — Series C
- Blue Heron Capital (https://capitalatlas.ai/funds/blue-heron-capital) — Series C
- Corridor Management (https://capitalatlas.ai/funds/corridor-management) — Series C
- UnityPoint Health Ventures (https://capitalatlas.ai/funds/unitypoint-health-ventures) — Series C
- OSF Ventures (https://capitalatlas.ai/funds/osf-ventures) — Series C